Home › Funds › Velan Capital Investment Management LP › HRTX
Velan Capital Investment Management LP position in HRTX
HERON THERAPEUTICS INC · Health Care
Velan Capital Investment Management LP reported holding 8,753,290 shares of HRTX (HERON THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$2.7M, representing 2.62% of its reported portfolio and ranking #13 among its reported holdings. Velan Capital Investment Management LP has disclosed HRTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Velan Capital Investment Management LP's HRTX position evolved
Velan Capital Investment Management LP first disclosed a stake in HRTX in Q3 2023 at 6,986,744 shares (US$7.2M). The position peaked in Q2 2024 at 6,986,744 shares, worth US$24.5M. Across 13 filings, Velan Capital Investment Management LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 11 time(s). The most recent filing (Q3 2026) shows 8,753,290 shares valued at US$2.7M. Notable position changes include a 25% increase in Q3 2025 (shares rose 3% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 6.99M | $7.20M | New |
| Q4 2023 | 6.99M | $11.88M | Hold |
| Q1 2024 | 6.99M | $19.35M | Hold |
| Q2 2024 | 6.99M | $24.45M | Hold |
| Q3 2024 | 6.99M | $13.90M | Hold |
| Q4 2024 | 6.99M | $10.69M | Hold |
| Q1 2025 | 6.99M | $15.37M | Hold |
| Q2 2025 | 6.99M | $14.46M | Hold |
| Q3 2025 | 8.75M | $11.03M | Add |
| Q4 2025 | 8.75M | $11.38M | Hold |
| Q1 2026 | 8.75M | $7.00M | Hold |
| Q2 2026 | 8.75M | $3.74M | Hold |
| Q3 2026 | 8.75M | $2.74M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About HRTX and 13F data
HRTX (HERON THERAPEUTICS INC) is a Health Care company. 6 other funds we track also report a position in HRTX — the largest reported positions include TANG CAPITAL MANAGEMENT LLC (US$2.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding HRTX
- TANG CAPITAL MANAGEMENT LLC 6.25M sh · $2.67M · Q2 2026
More on Velan Capital Investment Management LP
FAQ
How long has Velan Capital Investment Management LP held HRTX?
Velan Capital Investment Management LP has disclosed HRTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Velan Capital Investment Management LP's current position in HRTX?
As of Q3 2026, Velan Capital Investment Management LP holds 8.75M shares of HRTX (HERON THERAPEUTICS INC), valued at $2.74M, representing 2.62% of its reported portfolio and ranking #13.
Has Velan Capital Investment Management LP been buying or selling HRTX?
In the latest 13F filing (Q3 2026), Velan Capital Investment Management LP held unchanged its position in HRTX. The position peaked in Q2 2024 at 6.99M shares.
Which other funds hold HRTX?
Other major institutional holders of HRTX include TANG CAPITAL MANAGEMENT LLC, among 6 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.